Exploiting the Reversibility of Olefin Metathesis. Syntheses of Macrocyclic Trisubstituted Alkenes and (R,R)-(−)-Pyrenophorin by Fürstner, A. et al.
 S-1
SUPPORTING INFORMATION 
Exploiting the Reversibility of Olefin Metathesis. Syntheses of 
Macrocyclic Trisubstituted Alkenes and (R,R)-(−)-Pyrenophorin 
 
Alois Fürstner,* Oliver R. Thiel, and Lutz Ackermann 
Max-Planck-Institut für Kohlenforschung, D-45470 Mülheim/Ruhr, Germany 
e-mail: fuerstner@mpi-muelheim.mpg.de 
 
General. All reactions were carried out under Ar in pre-dried glassware using Schlenk 
techniques. The solvents were dried by distillation over the drying agents indicated and were 
stored and transferred under Ar: CH2Cl2 (P4O10), benzene (Na/K), THF (magnesium/ 
anthracene). Flash chromatography: Merck silica gel (230-400 mesh). NMR: Spectra were 
recorded on a Bruker DPX 300 spectrometer in the solvent indicated. Chemical shifts (δ) are 
given in ppm relative to TMS, coupling constants (J) in Hz. IR: Nicolet FT-7199, 
wavenumbers in cm-1. MS: Finnigan MAT 8200 (70 eV); HR-MS: Finnigan MAT SSQ 7000 
(70 eV). Elemental analyses: Dornis & Kolbe, Mülheim. Commercially available reagents 
(Aldrich, Fluka) were used as received. 
Ester 5. 1H-NMR (CD2Cl2, 300MHz) δ 5.90-5.70 (m, 1H), 5.05-4.85 (m, 2H), 4.80 (m, 1H), 
4.73 (m, 1H), 4.16 (t, 2H, J = 6.8 Hz), 2.35-2.24 (m, 4H), 2.10-2.00 (m, 2H), 1.75 (s, 3H), 
1.60-1.55 (m, 2H), 1.40-1.25 (m, 10H); 13C-NMR (CD2Cl2, 75 MHz) δ  173.6, 142.2, 139.4, 
113.9, 111.8, 62.3, 36.8, 34.3, 33.9, 29.4, 29.3, 29.2, 29.2, 29.0, 25.0, 22.3; IR (film): 3077, 
2927, 2855, 1739, 1651, 1641, 1456, 1376, 1170, 994, 909, 892 cm-1; MS (EI) m/z (rel. 
intensity)  252 ([M+], 4), 237 (1), 223 (2), 182 (3), 165 (3), 149 (9), 123 (4), 110 (6), 95 (12), 
81 (12), 68 (100), 55 (24), 41 (34); C16H28O2 (252.40) calcd.: C, 76.14; H, 11.18; found C, 
75.99; H 11.26. 
Compound 6. 1H-NMR (CDCl3, 300MHz) δ 5.36-5.33 (m, 2H), 4.77 (s, 2H), 4.70 (s, 2H), 
4.15 (t, 4H, J = 6.8 Hz), 2.33-2.23 (m, 8 H), 2.00-1.90 (m, 4H), 1.73 (s, 6H), 1.65-1.45 (m, 
4H), 1.40-1.15 (m, 20 H);  13C-NMR (CDCl3, 75 MHz) δ  173.8, 141.7, 130.3, 129.8, 112.2, 
62.4, 36.7, 34.3, 32.5, 29.7, 29.6, 29.5, 29.3, 29.3, 29.2, 29.1, 29.0, 27.2, 24.9, 22.4; IR (KBr): 
3077, 2925, 2854, 1737, 1652, 1456, 1376, 1171, 969, 891, 724 cm-1; MS (EI) m/z (rel. 
intrensity)  476 ([M+], 5), 391 (6), 321 (8), 303 (17), 95 (8), 69 (100), 41 (33). 
12-Methyl-1-oxa-2-oxo-cyclotetradec-11-ene (7). 1H-NMR (CDCl3, 300MHz) δ 5.23 (t, 1H, 
J = 7.7 Hz), 4.21 (t, 2H, J = 5.5 Hz), 2.40-2.28 (m, 4H), 2.06-1.99 (m, 2H), 1.63 (s, 3H), 1.61-
1.52 (m, 2H), 1.40-1.10 (m, 10H); 13C-NMR (CDCl3, 75 MHz) δ 174.1, 131.5, 127.9, 61.9, 
38.8, 34.9, 27.6, 27.0, 26.0, 25.9, 25.7, 24.1, 23.8, 15.3 ; IR (film) : 2930, 2858, 1733, 1456, 
1383, 1336, 1250, 1174, 1134, 1084, 1039  cm-1; MS (EI) m/z (rel. intensity)  224 ([M+], 51), 
209 (2), 195 (23), 177 (5), 167 (5), 154 (17), 136 (27), 109 (44), 95 (59), 81 (100), 68 (85), 55 
(40), 41 (50); HR-MS calcd. 224.17763; found 224.17763. 
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Table S-1. Key features of previous total syntheses21,22 of pyrenophorin 8.a 




Rac / (−)c Principal 
Investigator 
Ref. 
Dilactonization (Mitsunobu) 24 9 1 d/l + meso Gerlach 19b 
 23 11 <1 d/l + meso Bakuzis 19c 
 17 9 <<6 d/l + meso Takei 19d 
 20 10 <1 d/l + meso Bates 19g 
 50 9 <7 d/l + meso Hirao 19i 
 75 10 15 (−) Seebach 14b 
 45-55 8 20 (−) Seebach 14c 
 44 >10 <7 (−) Kibayashi 14f 
 47 8 ? d/l + meso Fujisawa 19k 
 44 12 3 (−) Matsushita 14g 
Dilactonization (Me2Sn=O) 34 9 2 d/l + meso Steliou 19f 
Dilactonization (lipase catalyzed) 44 16 <2 (−) Ohta 14i 
Dilactonization [(EtO)2P(O)Cl] 60 8 3 d/l + meso Wakamatsu 19h 
Stepwise esterification 60 14 1 d/l + meso Colvin 19a 
Olefination (Wittig) 83 9 4 d/l + meso Le Floc’h 19j 
Olefination (Horner) 52 >10 <6 (−) Takano 14d 
Olefination (sulfoxide) 56 11 14 (−) Nokami 14h 
1,3-dipolar cycloaddition 85 7 17 d/l + meso Takei 19e 
Stille coupling 38 7 12(23) (−) Baldwin 14e 
 
a
 In some cases it is difficult to determine the precise number of steps as well as the overall yield of a given 
sequence for the following reasons: (i) eventually, some syntheses of 8 commence with substrates which 
themselves must be prepared by several steps; (ii) ambiguities arise where several reactions are carried out in “one 
pot” without isolating or rigorously purifying the intermediates; (iii) in some cases, the yield of individual steps are 
not reported. Therefore the numbers compiled in Table S-1 are only meant to provide a gross picture and refer to 
the sequence as traced back to commercially available starting materials. b Refers to the method and yield of the 
reaction which forms the macrocyclic ring. c It is worth mention that cyclo-dimerizations of racemic precursors 
necessarily lead to the formation of mixtures of rac-8 and meso-8 and are therefore inherently less productive than 
cyclizations of optically active substrates. 
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56, 1803. (l) Zimmer, R.; Collas, M.; Roth, M.; Reissig, H-U. Liebigs Ann. Chem. 1992, 709. (m) Gu, J.-X.;  Li; Z.-
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(R)-Hept-6-en-2-ol (10). A solution of 3-butenylmagnesium bromide [prepared from 4-
bromo-1-butene (4.24 g, 31.4 mmol) and Mg (820 mg, 34.6 mmol)] in THF (30 mL) is added 
over 30 min to a suspension of (R)-methyloxirane (1.4 mL, 19.9 mmol) and CuCl(COD) (592 
mg, 2.84 mmol) in THF (25 mL) at -78 °C. The mixture is allowed to warm to ambient 
temperature overnight. The reaction is quenched by addition of aq. sat. NH4Cl (30 ml) and the 
aqueous layer is extracted with Et2O (3 x 30 mL). Drying of the combined organic phases 
over Na2SO4, evaporation of the solvent followed by flash chromatography of the crude 
product (pentane/Et2O, 4 : 1) affords product 10 as a colourless oil (1.69 g, 75 %). 1H-NMR 
(CD2Cl2, 300 MHz) δ 5.82 (1H, ddt, J = 17.0, 9.8, 6.7 Hz), 5.07 - 4.92 (2H, m), 3.82 - 3.69 
(1H, m), 2.11 - 2.03 (2H, m), 1.49 - 1.34 (5H, m), 1.15 (3H, d, J = 6.1 Hz); 13C-NMR 
(CD2Cl2, 75.5 MHz) δ 139.3, 114.6, 68.1, 39.2, 34.1, 25.5, 23.7; [α]20D = −10.8 (0.82, 
CHCl3) [ref23: [α]26D of the (S)-enantiomer: +10.4 (0.79, CHCl3)];  IR (neat) 3356, 3077, 
2969, 2932, 2861, 1641, 1459, 1440, 1416, 1374, 1122, 996, 910 cm-1; MS (EI) m/z (rel. 
intensity) 114 ([M+], < 1), 96 (10), 81 (41), 71 (19), 54 (49), 45 (100).  
(R)-Acrylic acid 1-methyl-hex-5-enyl ester (11). A solution of acrylic acid chloride (0.89 
mL, 11 mmol) in CH2Cl2 (25 mL) is added slowly at 0 °C to a solution of alcohol 10 (1.14 g, 
10 mmol) and triethylamine (4.2 mL, 30 mmol) in CH2Cl2 (25 mL). After stirring at r. t. for 
14 h the organic layer is washed with aq. HCl (1M, 3 x 25 mL) and brine (25 mL). Drying of 
the organic phases over Na2SO4, evaporation of the solvent and flash chromatography of the 
crude material (hexanes/ethyl acetate, 30:1) affords ester 11 as a colourless oil (1.37 g, 82 %). 
1H-NMR (CDCl3, 300 MHz) δ 6.35 (1H, dd, J = 17.3, 1.6 Hz), 6.07 (1H, dd, J = 17.3, 10.4 
Hz), 5.83 - 5.68 (2H, m), 5.03 - 4.89 (3H, m), 2.08 - 1.98 (2H, m), 1.68 - 1.32 (4H, m), 1.21 
(3H, d, J = 6.3 Hz); 13C-NMR (CDCl3, 75.5 MHz) δ 165.8, 138.4, 130.1, 129.0, 114.7, 71.0, 
35.3, 33.4, 24.6, 19.9; [α]20D = −8.6 (1.35, CH2Cl2); IR (neat) 3078, 2978, 2937, 2864, 1723, 
1639, 1620, 1406, 1381, 1296, 1272, 1199, 1128, 1047, 986, 912, 810 cm-1; MS (EI) m/z (rel. 
intensity) 168 ([M+], < 1), 125 (1), 111 (2), 96 (16), 81 (32), 67 (12), 55 (100), 41 (20), 27 
(26). HR-MS (CI) (C10H16O2 + H) calcd. 169.1229; found 169.1228. C10H16O2 (168.24) 
calcd. C 71.39, H 9.59; found C 71.48, H 9.64. 
(3E,8R,11E,16R)-8,16-Dimethyl-1,9-dioxa-cyclohexadeca-3,11-diene-2,10-dione (12). 
Ruthenium complex 4 (42 mg, 0.05 mmol, 5 mol-%) is added to a refluxing solution of diene 
11 (168 mg, 1 mmol) in CH2Cl2 (500 mL). The reaction is quenched after 50 min by addition 
of ethylvinyl ether (2 mL). Evaporation of the solvent and flash chromatography (hexanes/ 
ethyl acetate, 30:1→20:1) affords diolide 12 as a colourless oil (52.4 mg, 37 %). 1H-NMR 
(CD2Cl2, 300 MHz) δ 6.93 (2H, ddd, J = 15.6, 7.7, 5.7 Hz), 5.81 (2H, dt, J = 15.6, 1.6 Hz), 
5.01 - 4.91 (2H, m), 2.35 - 2.09 (4H, m), 1.78 - 1.48 (8H, m), 1.22 (6H, d, J = 6.4 Hz); 13C-
NMR (CD2Cl2, 75.5 MHz) δ 166.0, 148.6, 122.9, 70.4, 33.4, 31.0, 22.3, 19.1; [α]20D = −56.2 
(0.68, CH2Cl2) [ref.3c: [α]21D = −32.5 (0.53, benzene)]; IR (neat) 2975, 2936, 2870, 1716, 
1655, 1455, 1355, 1268, 1211, 1172, 1134, 1084, 983, 869, 842 cm-1; MS (EI) m/z (rel. 
intensity) 280 ([M+], 4), 262 (13), 140 (65), 122 (100), 95 (75), 81 (72), 68 (34), 55 (30), 43 
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(24). HR-MS (CI) (C16H24O4 + H) calcd. 281.1753; found 281.1756. The analytical data are 
in full agreement with those reported in the literature.16b 
(−)-Pyrenophorin (8). Chromium trioxide (150 mg, 1.5 mmol) is added in small portions to a 
mixture of acetic anhyride (0.6 mL) and acetic acid (1.2 mL). The mixture was cooled to 0 °C 
and diluted with benzene (1 mL). After stirring at 0 °C for 30 min, a solution of substrate 12 
(42.0 mg, 0.15 mmol) in benzene (1 mL) was added. After stirring at 0 °C for 30 min, the 
reaction is quenched with chilled water (1 mL) and neutralised with aq. NaOH (1M, 5 mL). 
The aqueous phase is extracted with ethyl acetate (3 x 10 mL), the combined organic layers 
are washed with sat. aq. NaHCO3 (10 mL), dried (Na2SO4), and evaporated. Flash 
chromatography (hexanes/ethyl acetate, 4:1) of the residue affords the title compound 8 as 
colourless crystals (25.0 mg, 54 %). 1H-NMR (CD2Cl2, 300 MHz) δ 6.92 (2H, d, J = 16.0 
Hz), 6.46 (2H, d, J = 16.0 Hz), 5.06 - 4.95 (2H, m), 2.71 - 2.49 (4H, m), 2.12 - 2.05 (4H, m), 
1.27 (6H, d, J = 6.3 Hz); 13C-NMR (CD2Cl2, 75.5 MHz) δ 200.1, 165.3, 140.0, 131.6, 72.5, 
37.5, 32.4, 19.7; [α]20D = −53.3 (0.33, acetone) [ref.16b: [α]D = −54.5 (0.48, acetone)]; IR 
(neat) 3066, 2980, 2917, 2873, 1716, 1692, 1632, 1448, 1352, 1295, 1184, 1125, 1054, 1003, 
896, 744, 573 cm-1; MS (EI) m/z (rel. intensity) 308 ([M+], 7), 264 (4), 195 (4), 171 (2), 155 
(39), 138 (100), 109 (15), 99 (34), 82 (42), 68 (9), 55 (41). HR-MS (EI) (C16H20O6) calcd. 
308.1260; found 308.1260. The analytical data are in full agreement with those reported in the 
literature.16b 
(3E,8R,11E,16R,19E,24R)-8,16,24-Trimethyl-1,9,17-trioxa-cyclotetracosa-3,11,19-triene-
2,10,18-trione (13).16c Ruthenium complex 2 (20.5 mg, 0.025 mmol) is added to a refluxing 
solution of diene 11 (84 mg, 0.5 mmol) in CH2Cl2 (50 mL). The solution is refluxed for 15 h. 
Evaporation of the solvent and flash chromatography (hexanes/ethyl acetate, 20:1) affords 
product 13 as a colourless oil (56.6 mg, 81 %). 1H-NMR (CD2Cl2, 300 MHz) δ 6.89 (3H, ddd, 
J = 15.6, 7.9, 5.9 Hz), 5.78 (3H, dt, J = 15.6, 1.3 Hz), 4.99 - 4.88 (3H, m), 2.31 - 2.04 (6H, m), 
1.77 - 1.42 (12H, m), 1.22 (9H, d, J = 6.3 Hz); 13C-NMR (CD2Cl2, 75.5 MHz) δ 166.4, 148.8, 
122.1, 70.5, 36.2, 32.4, 24.6, 20.4; IR (neat) 2976, 2935, 2865, 1716, 1653, 1458, 1379, 1358, 
1310, 1270, 1203, 1176, 1131, 1091, 1064, 1016, 990 cm-1; MS (EI) m/z (rel. intensity) 420 
([M+], 3), 402 (2), 280 (4), 262 (8), 140 (35), 122 (100), 95 (56), 81 (58), 68 (22), 55 (24), 43 
(12). 
 
